Hi stillHoping

As others have pointed out, Rituxmab is a genetically engineered monoclonal antibody which is indicated on-label for treatment of various B cell associated cancers and other diseases.

It has sometimes been used off-label for people with anti-MAG associated neuropathy. There are clinical reports which indicate that it can make things worse, not better, for people with neuropathy (http://www.jns-journal.com/article/S...501-2/abstract.).

I suggest that you talk about this with your care team.